Form 8-K - Current report:
SEC Accession No. 0000855654-06-000009
Filing Date
2006-02-07
Accepted
2006-02-07 16:33:30
Documents
4
Period of Report
2006-02-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 IMMUNOGEN, INC. FORM 8-K form8-k.htm 8-K 29095
2 EXHIBIT 10.1 IMMUNOGEN, INC. RESTATED STOCK OPTION PLAN exhibit10_1.htm EX-10.1 141836
3 EXHIBIT 10.2 FORM OF INCENTIVE STOCK OPTION AGREEMENT exhibit10_2.htm EX-10.2 63957
4 EXHIBIT 10.3 FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT exhibit10_3.htm EX-10.3 56134
  Complete submission text file 0000855654-06-000009.txt   292497
Mailing Address 128 SIDNEY ST CAMBRIDGE MA 02139
Business Address 128 SIDNEY ST CAMBRIDGE MA 02139 6179952506
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

EIN.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0606
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 06585847
SIC: 2834 Pharmaceutical Preparations